Extension Study of ABBV-8E12 in Patients With Progressive Supranuclear Palsy (PSP) Who Completed Study C2N-8E12-WW-104
Condition:   Progressive Supranuclear Palsy (PSP) Intervention:   Drug: ABBV-8E12 Sponsor:   AbbVie Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 29, 2018 Category: Research Source Type: clinical trials